Myasthenia gravis (MG) in children and adolescents to age 18 -- juvenile MG -- includes clinically significant developmental ...

Myasthenia gravis affects both men and women and occurs across all races ... Testing included repetitive nerve stimulation, single-fiber electromyography (EMG), nerve conduction studies (NCS), ...

People with generalized myasthenia gravis (MG) experience psychiatric symptoms including anxiety, depression, and post-traumatic stress disorder (PTSD) at rates higher than that of the general ...

SEOUL, South Korea, June 02, 2025--ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared ...

ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug (IND ...

Last year, the FDA placed a partial clinical hold on tolebrutinib phase 3 trials in MS and myasthenia gravis after cases of drug-induced liver injury were observed, with recruitment of new studies ...

Tuesday, June 3, 2025. News & Perspective Drugs & Diseases CME & Education Drugs & Diseases CME & Education ...

For every subject in Class 11, the Punjab School Education Board (PSEB) has published the most recent curriculum. Based on ...

Myasthenia gravis is a chronic autoimmune condition that causes muscle weakness. While there is no cure yet, there are treatments that offer symptom relief. However, in the past decade, this has ...

HOUSE, PA — Johnson & Johnson (NYSE: JNJ) has unveiled new data demonstrating the efficacy of IMAAVY™ (nipocalimab-aahu) for the treatment of generalized myasthenia gravis (gMG). Presented at the ...